{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:59:16Z","timestamp":1788209956473,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T00:00:00Z","timestamp":1361404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11095-013-0997-4","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T22:10:41Z","timestamp":1361398241000},"page":"1586-1596","source":"Crossref","is-referenced-by-count":22,"title":["Inhalable Powder Formulation of Pirfenidone with Reduced Phototoxic Risk for Treatment of Pulmonary Fibrosis"],"prefix":"10.1007","volume":"30","author":[{"given":"Satomi","family":"Onoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"997_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2466-12-24","volume":"12","author":"K Hisatomi","year":"2012","unstructured":"Hisatomi K, Mukae H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, et al. Pirfenidone inhibits TGF-ss1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells. BMC Pulm Med. 2012;12:24.","journal-title":"BMC Pulm Med"},{"key":"997_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3565(24)35110-9","volume":"291","author":"SN Iyer","year":"1999","unstructured":"Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther. 1999;291:367\u201373.","journal-title":"J Pharmacol Exp Ther"},{"key":"997_CR3","first-page":"166","volume":"7","author":"J Lasky","year":"2004","unstructured":"Lasky J. Pirfenidone. IDrugs. 2004;7:166\u201372.","journal-title":"IDrugs"},{"key":"997_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","volume":"20","author":"CJ Schaefer","year":"2011","unstructured":"Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K. Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev. 2011;20:85\u201397.","journal-title":"Eur Respir Rev"},{"key":"997_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(01)01209-2","volume":"426","author":"M Corbel","year":"2001","unstructured":"Corbel M, Lanchou J, Germain N, Malledant Y, Boichot E, Lagente V. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice. Eur J Pharmacol. 2001;426:113\u201321.","journal-title":"Eur J Pharmacol"},{"key":"997_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1752-699X.2012.00302.x","volume":"6","author":"O Hilberg","year":"2012","unstructured":"Hilberg O, Simonsen U, du Bois R, Bendstrup E. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis. Clin Respir J. 2012;6:131\u201343.","journal-title":"Clin Respir J"},{"key":"997_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd3495","volume":"10","author":"L Richeldi","year":"2011","unstructured":"Richeldi L, Yasothan U, Kirkpatrick P. Pirfenidone. Nat Rev Drug Discov. 2011;10:489\u201390.","journal-title":"Nat Rev Drug Discov"},{"key":"997_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","volume":"35","author":"H Taniguchi","year":"2010","unstructured":"Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35:821\u20139.","journal-title":"Eur Respir J"},{"key":"997_CR9","doi-asserted-by":"crossref","unstructured":"Carter NJ. Pirfenidone: in idiopathic pulmonary fibrosis. Drugs. 2011;71:1721\u20131732.","DOI":"10.2165\/11207710-000000000-00000"},{"key":"997_CR10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1517\/14740338.6.4.431","volume":"6","author":"KR Steinand","year":"2007","unstructured":"Steinand KR, Scheinfeld NS. Drug-induced photoallergic and phototoxic reactions. Expert Opin Drug Saf. 2007;6:431\u201343.","journal-title":"Expert Opin Drug Saf"},{"key":"997_CR11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/157488609788173044","volume":"4","author":"S Onoue","year":"2009","unstructured":"Onoue S, Seto Y, Gandy G, Yamada S. Drug-induced phototoxicity; an early in vitro identification of phototoxic potential of new drug entities in drug discovery and development. Curr Drug Saf. 2009;4:123\u201336.","journal-title":"Curr Drug Saf"},{"key":"997_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1208\/s12248-011-9292-7","volume":"13","author":"Y Seto","year":"2011","unstructured":"Seto Y, Inoue R, Ochi M, Gandy G, Yamada S, Onoue S. Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones. AAPS J. 2011;13:482\u201392.","journal-title":"AAPS J"},{"key":"997_CR13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jps.22299","volume":"100","author":"S Onoue","year":"2011","unstructured":"Onoue S, Aoki Y, Kawabata Y, Matsui T, Yamamoto K, Sato H, et al. Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases. J Pharm Sci. 2011;100:622\u201333.","journal-title":"J Pharm Sci"},{"key":"997_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2009.04.014","volume":"138","author":"S Onoue","year":"2009","unstructured":"Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S. In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy. J Control Release. 2009;138:16\u201323.","journal-title":"J Control Release"},{"key":"997_CR15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11095-005-8497-9","volume":"23","author":"S Onoueand","year":"2006","unstructured":"Onoueand S, Tsuda Y. Analytical studies on the prediction of photosensitive\/phototoxic potential of pharmaceutical substances. Pharm Res. 2006;23:156\u201364.","journal-title":"Pharm Res"},{"key":"997_CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejps.2009.04.002","volume":"37","author":"S Misaka","year":"2009","unstructured":"Misaka S, Sato H, Yamauchi Y, Onoue S, Yamada S. Novel dry powder formulation of ovalbumin for development of COPD-like animal model: Physicochemical characterization and biomarker profiling in rats. Eur J Pharm Sci. 2009;37:469\u201376.","journal-title":"Eur J Pharm Sci"},{"key":"997_CR17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jpba.2008.03.026","volume":"47","author":"S Onoue","year":"2008","unstructured":"Onoue S, Kawamura K, Igarashi N, Zhou Y, Fujikawa M, Yamada H, et al. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: Classification criteria and application to drug candidates. J Pharm Biomed Anal. 2008;47:967\u201372.","journal-title":"J Pharm Biomed Anal"},{"key":"997_CR18","doi-asserted-by":"crossref","unstructured":"Onoue S, Hosoi K, Wakuri S, Iwase Y, Yamamoto T, Matsuoka N et al. Establishment and intra-\/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation. J Appl Toxicol:in press (2012). doi: 10.1002\/jat.2776 .","DOI":"10.1002\/jat.2776"},{"key":"997_CR19","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jps.21964","volume":"99","author":"S Onoue","year":"2010","unstructured":"Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci. 2010;99:1871\u201381.","journal-title":"J Pharm Sci"},{"key":"997_CR20","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/jps.2600721023","volume":"72","author":"Y Matsudaand","year":"1983","unstructured":"Matsudaand Y, Masahara R. Photostability of solid-state ubidecarenone at ordinary and elevated temperatures under exaggerated UV irradiation. J Pharm Sci. 1983;72:1198\u2013203.","journal-title":"J Pharm Sci"},{"key":"997_CR21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/13543776.18.4.429","volume":"18","author":"S Onoue","year":"2008","unstructured":"Onoue S, Hashimoto N, Yamada S. Dry powder inhalation systems for pulmonary delivery of therapeutic peptides and proteins. Expert Opin Ther Patents. 2008;18:429\u201342.","journal-title":"Expert Opin Ther Patents"},{"key":"997_CR22","first-page":"652","volume":"45","author":"S Suarezand","year":"2000","unstructured":"Suarezand S, Hickey AJ. Drug properties affecting aerosol behavior. Respir Care. 2000;45:652\u201366.","journal-title":"Respir Care"},{"key":"997_CR23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labirisand","year":"2003","unstructured":"Labirisand NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:588\u201399.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"997_CR24","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.rmed.2010.03.019","volume":"104","author":"A Pesci","year":"2010","unstructured":"Pesci A, Ricchiuti E, Ruggiero R, De Micheli A. Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us? Respir Med. 2010;104 Suppl 1:S70\u20133.","journal-title":"Respir Med"},{"key":"997_CR25","first-page":"138","volume":"20","author":"KM Beeh","year":"2003","unstructured":"Beeh KM, Beier J, Kornmann O, Buhl R. Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:138\u201343.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"997_CR26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cca.2005.06.008","volume":"364","author":"EG Tzortzaki","year":"2006","unstructured":"Tzortzaki EG, Tsoumakidou M, Makris D, Siafakas NM. Laboratory markers for COPD in \u201csusceptible\u201d smokers. Clin Chim Acta. 2006;364:124\u201338.","journal-title":"Clin Chim Acta"},{"key":"997_CR27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425240903089310","volume":"6","author":"S Onoue","year":"2009","unstructured":"Onoue S, Misaka S, Kawabata Y, Yamada S. New treatments for chronic obstructive pulmonary disease and viable formulation\/device options for inhalation therapy. Expert Opin Drug Deliv. 2009;6:793\u2013811.","journal-title":"Expert Opin Drug Deliv"},{"key":"997_CR28","first-page":"41","volume-title":"DDS conference","author":"Y Seto","year":"2011","unstructured":"Seto Y, Aoki Y, Inoue R, Kojo Y, Kato M, Onoue S, et al. Development of dry powder inhaler system for reducing phototoxic risk. In: Oku N, editor. DDS conference, vol. 20. Shizuoka: Biomedical Research Press; 2011. p. 41\u20136."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-0997-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-013-0997-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-0997-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:48:02Z","timestamp":1745963282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-013-0997-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s11095-013-0997-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}